Abstract
AbstractCystic fibrosis (CF) is the most common genetic disease in the Caucasion population. Thanks to the CFTR modulators therapy, life expectancy will significantly improve. New therapeutic challenges can be expected, including diseases associated with ageing and higher incidence of cancer, as evidenced by recent epidemiological studies. The increasing incidence of tumors includes also breast cancer. The risk of breast cancer is higher in CF patients compared to the general population. Sex hormones, especially estrogens, also affect on the pathophysiology and immunology of the CF. Previous research, has demonstrated unequivocal survival rates for female CF patients compared to their male counterparts. Is demonstrated, that chemotherapy used for breast cancer affects the CFTR channel and CFTR modulator therapy has frequent side effects on breast tissue. In this review, we focus on the effects of female sex hormones on CF disease, pathophysiological relationships between CF and breast cancer, and the impact of antitumor treatment on both, malignant disease and CF. The potential for further investigation is also discussed.
Funder
Czech Pneumological and Phthisiological Society
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics (clinical),General Medicine
Reference34 articles.
1. ECFSPR Report. 2019. [cited 2022 14th July]. Available from: https://www.ecfs.eu/sites/default/files/general-content-files/working-groups/ecfs-patient-registry/ECFSPR_Report_2019_v1_16Feb2022.pdf.
2. Cystic Fibrosis Canada. The Canadian Cystic Fibrosis Registry 2017 Annual Data Report. [cited 2022 14th July]. Available from: www.cysticfibrosis.ca/blog/2017-registry-annual-data-report/.
3. Archangelidi O, Cullinan P, Simmonds NJ, Mentzakis E, Peckham D, Bilton D, et al. Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study. J Cyst Fibros. 2022;21(2):302–8.
4. Alicandro G, Bisogno A, Rota M, Padoan R, Colombo C. No gender differences in growth patterns in a cohort of children with cystic fibrosis born between 1986 and 1995. Clin Nutr. 2019;38(4):1782–7.
5. Schram CA, Stephenson AL, Hannam TG, Tullis E. Cystic fibrosis (CF) and ovarian reserve: a cross-sectional study examining serum anti-mullerian hormone (AMH) in young women. J Cyst Fibros. 2015;14(3):398–402.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献